Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Aug 1;43(7):803-807.
doi: 10.1097/MAO.0000000000003575.

Residual Cholesteatoma After Endoscopic-Assisted Canal Wall-Up Tympanomastoidectomy: A Randomized Controlled Trial

Maurício Noschang Lopes da Silva  1 , Sady Selaimen da Costa, Fábio André Selaimen  2 , Felipe da Costa Huve  2 , Alice Lang Silva  2 , Fernanda Dias Toshiaki Koga  2 , Luciana Lima Martins-Costa  2 , Marcel Bernard Rosa Nery  3 , Marcos Zanardini  3 , Neil Sperling  4
Affiliations
Randomized Controlled Trial

Residual Cholesteatoma After Endoscopic-Assisted Canal Wall-Up Tympanomastoidectomy: A Randomized Controlled Trial

Maurício Noschang Lopes da Silva et al. Otol Neurotol. .

Abstract

Objective: This study aimed to determine the effectiveness of using endoscopes in reducing recidivism secondary to residual cholesteatoma after canal wall-up tympanomastoidectomy.

Study design: Randomized clinical trial.

Setting: Tertiary referral center.

Patients: Patients with cholesteatoma, aged 7 to 70 years.

Interventions: Subjects were randomly allocated into two groups: endoscopic-assisted canal wall-up (EACWU; group 1) and conventional canal wall-up (CWU; group 2) techniques. Pars flaccida and pars tensa subgroups were analyzed according to the anatomic location of cholesteatoma origin.

Main outcome measures: Presence or absence of residual cholesteatoma, based on second look surgery, diffusion-weighted magnetic resonance imaging, or video-otoscopy at 12 and 18 months after surgery.

Results: In total, 57 ears were analyzed: 29 in group 1 and 28 in group 2. Group 1 revealed residual disease in 17.2% of ears, whereas group 2 had residual disease in 35.7% (p > 0.05) of the ears. In the pars tensa cholesteatoma subgroup, the incidence of residual disease was 13.3% for EACWU and 47.1% for the CWU technique (p < 0.05). A tendency of reduced incidence was observed for cholesteatoma due to residual disease using EACWU. In addition, a statistically significant reduction in the residual disease was observed in the subgroup of pars tensa cholesteatomas. In this subgroup, the relative risk was 0.28, and the number needed to treat was 4.6.

Conclusion: The use of the endoscope reduces the incidence of recidivism secondary to residual disease in pars tensa cholesteatomas. Endoscopic-assisted surgery may be useful in cases with an indication for canal wall-up tympanomastoidectomy.

Level of evidence: 1b.

PubMed Disclaimer

Conflict of interest statement

The authors disclose no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Costa SS, Cruz OLM, Oliveira JAA. Otorhinolaryngology (Principles and Practice) . 2nd ed. Porto Alegre, Brazil: Artmed; 2006. 309 p.
    1. Jackler RK. The surgical anatomy of cholesteatoma. Otolaryngol Clin North Am 1989;22:883–96.
    1. Luntz M, Barzilai R. Middle ear cholesteatoma. Harefuah 2021;160:316–22. In Hebrew. PMID: 34028225.
    1. Costa SS, Souza LCA, Andrade MI. Procedures on the temporal bone: Reviewing the nomenclature. BJORL 57:170–9.
    1. Wilson KF, Hoggan RN, Shelton C. Tympanoplasty with intact canal wall mastoidectomy for cholesteatoma: Long-term surgical outcomes. Otolaryngol Head Neck Surg 2013;149:292–5.

Publication types